DH334, a beta-carboline anti-cancer drug, inhibits the CDK activity of budding yeast.

Cancer biology & therapy

Volumn 6, Issue 8, 2007, Pages 1193-1199

  Li, Yan ^a   Liang, Fengshan ^a   Jiang, Wei ^a   Yu, Fusheng ^a   Cao, Rihui ^a   Ma, Qinghe ^a   Dai, Xiuyong ^a   Jiang, Jiandong ^a   Wang, Yanchang ^a   Si, Shuyi ^a  

^a INSTITUTE OF MEDICINAL BIOTECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOLINE DERIVATIVE; CYCLIN A; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; DH334 COMPOUND; FUNGAL PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GROWTH, DEVELOPMENT AND AGING; PHOSPHORYLATION; SACCHAROMYCES;

ANTINEOPLASTIC AGENTS; CARBOLINES; CELL PROLIFERATION; CYCLIN A; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASES; FUNGAL PROTEINS; PHOSPHORYLATION; SACCHAROMYCETALES;

EID: 39749162235     PISSN: None     EISSN: 15558576     Source Type: Journal    
DOI: None     Document Type: Article

References (0)